Valuation: Cello Health plc

Market Cap 179M 155M 144M 133M 249M 17.02B 253M 1.69B 665M 8.53B 672M 657M 28.2B P/E 2018
18.1x
P/E 2019 -155x
Enterprise Value 182M 158M 147M 135M 254M 17.36B 258M 1.73B 679M 8.7B 685M 670M 28.77B EV / Sales 2018
0.66x
EV / Sales 2019 0.88x
Free-Float
-
Yield 2018
3.47%
Yield 2019 1.6%
Manager TitleAgeSince
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 51 13/08/2020
Director/Board Member 47 15/12/2023
Date Insider Type Main position Quantity % Market Cap.
30/03/20 Free 80,000 0.0752%
30/03/20 Free

Chief Operating Officer

265,000 0.2492%
30/03/20 Free

Chief Financial Officer

250,000 0.2351%

Financials

2018 2019
Net sales 166M 143M 134M 123M 231M 15.76B 234M 1.57B 616M 7.9B 622M 608M 26.11B 167M 144M 135M 124M 232M 15.87B 236M 1.58B 620M 7.96B 626M 613M 26.3B
Net income 6.62M 5.72M 5.35M 4.9M 9.22M 630M 9.37M 62.72M 24.62M 316M 24.85M 24.31M 1.04B -943K -816K -762K -699K -1.31M -89.75M -1.34M -8.94M -3.51M -44.98M -3.54M -3.46M -149M
Net Debt -6.34M -5.48M -5.12M -4.7M -8.84M -603M -8.98M -60.1M -23.59M -302M -23.81M -23.29M -1B 3.58M 3.09M 2.89M 2.65M 4.99M 340M 5.06M 33.9M 13.31M 171M 13.43M 13.14M 564M
Logo Cello Health plc
Cello Health plc, formerly Cello Group plc, is a United Kingdom-based healthcare and consumer strategic marketing company. The Company is engaged in providing market research, consulting and direct marketing services. The Company provides a range of biotech, diagnostics, devices and other non-healthcare clients. The Company operates through two segments: Cello Health and Cello Signal. The Cello Health Division provides market research, consulting and communications services principally to the Company's pharmaceutical and healthcare clients. The Cello Signal Division provides market research and direct communications services to the Company's consumer facing clients. The Company delivers its services from office networks in the United Kingdom, the United States and Singapore.
Employees
-
Sector
-